Trial Profile
Phase I/IIa Study of the Safety, Immunogenicity and Preliminary Efficacy After Sporozoite Challenge of FMP2.1/AS01B and FMP2.1/AS02A Candidate Malaria Vaccines Administered Intramuscularly at Months 0, 1, and 2 in Malaria-naive Adults Living in the United States
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Malaria vaccine (Primary) ; AS01B; AS02
- Indications Falciparum malaria; Malaria
- Focus Adverse reactions
- 11 Jun 2011 New trial record